Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
 
 
The extraordinary growth of social media has been a global phenomenon, but life sciences companies have been slow to join in. In a world where 1.28 billion people comment and share on Facebook, more than one billion people watch videos on YouTube,...
 
 
 
 
Our Accenture Accelerated R&D Services European regulatory team held a summit in London with pharma and biotech global regulatory operations leaders. The Operational Vision in Regulatory summit provided a facilitated forum for regulatory leaders...
 
 
 
 
As the healthcare industry shifts its focus toward patient outcomes and outcome-based results, companies wanting to get ahead of the competition will need to expand their role and develop mutually beneficial collaborative partnerships. At Accenture,...
 
 
 
 
There is some big money at stake in healthcare as a result of the digital revolution. Accenture estimates that digital disruption has the potential to unlock more than $100 billion of commercial value in the United States over a five-year period thr...
 
 
 
 
In the digital healthcare revolution, life sciences companies must be prepared to capitalize on and defend against digital disruptions to avoid being overtaken by more nimble digital players or more innovative competitors. Life sciences companies ne...
 
 
 
 
I recently represented Accenture at the third annual Beyond the Pill conference, held on January 27-29 in Princeton, NJ. A wide range of interested parties attended the conference, from big pharma (Pfizer, Bristol-Meyers Squibb, Johnson & Johnso...
 
 
 
 
For the last four years, I have had the opportunity to meet with a group of MBA and MHA (Masters in Health Administration) students from the Healthcare and Biotech Club as well as the Consulting Club of Cornell Johnson School of Business to give a c...
 
 
 
 
Approval delays can cost pharmaceutical companies years in development time and potentially millions in lost sales, which is why it’s critical to have all the right capabilities clearly defined early in the drug development process. Without the incl...
 
 
 
 
When news recently broke of Novartis’ collaboration with Google on a blood sugar-tracking contact lens, the story made headlines around the globe.1 The news comes as the life sciences industry reaches a tipping point between developing drugs, and ...
 
 
 
 
Last week, from January 12 to 15, I had the privilege of attending the 33rd J.P. Morgan Healthcare Conference in San Francisco. The conference was packed with side meetings, speaker programs and networking events focused on the major changes in th...
 
 
 Next >>
About the Authors
Anne O'Riordan
Anne O'Riordan is a Senior Managing Director responsible for Accenture's Global Life Sciences Practice. Worked throughout Europe, th...
 
Andrea Brueckner
Andrea Brueckner is a Managing Director in Accenture’s Life Sciences practice. She also leads the practice in Europe, Africa and Lat...
 
Doug Mowen
Doug Mowen is a Managing Director for Accenture’s Medical Technology Practice. With 25 years of experience and 15 years serving the ...
 
James_Crowley
James Crowley is a Managing Director and Life Sciences Lead within Accenture Strategy. In his current role he focuses on helping C-s...
 
Jeff Elton
Jeff Elton is a Managing Director of Accenture Life Sciences, with broad responsibilities for the strategy and partnerships f...
 
Kevin Julian
Kevin Julian is a Managing Director and Global Lead for Accenture's Life Sciences Accelerated R&D Services. Previously he was re...
 
Shawn Roman
Shawn Roman is a Managing Director in Accenture Life Sciences and leads the North America Commercial Services practice. Mr. Roman ha...
 
Tom Schwenger
Tom Schwenger is a Senior Managing Director and the Life Sciences North America Client Service Group Lead. In this role, Tom is resp...
 
 

 

By using this site you agree that we can place cookies on your device. See our privacy statement for details.